Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
66.8 GBX | -4.57% |
|
-3.19% | -0.30% |
Jul. 08 | EU tariffs hit growth in China's electric car exports, industry body official says | RE |
Jul. 08 | China's car sales slide in June, falling for a third month | RE |
Summary
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
Strengths
- Before interest, taxes, depreciation and amortization, the company's margins are particularly high.
- Margins returned by the company are among the highest on the stock exchange list. Its core activity clears big profits.
- Thanks to a sound financial situation, the firm has significant leeway for investment.
- Analysts covering this company mostly recommend stock overweighting or purchase.
- Analyst opinion has improved significantly over the past four months.
Weaknesses
- The firm trades with high earnings multiples: 24.29 times its 2024 earnings per share.
- The company's "enterprise value to sales" ratio is among the highest in the world.
- In relation to the value of its tangible assets, the company's valuation appears relatively high.
- The company's earnings releases usually do not meet expectations.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Pharmaceuticals
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-0.30% | 368M | C+ | ||
+62.66% | 854B | C+ | ||
+40.42% | 636B | B | ||
-4.37% | 361B | C+ | ||
+17.16% | 324B | B- | ||
+9.87% | 301B | C+ | ||
+15.66% | 247B | B+ | ||
+4.21% | 230B | A+ | ||
+17.90% | 228B | B- | ||
+14.86% | 177B | C+ |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- CIR Stock
- Ratings NIOX Group Plc